Brandinium

Trademark search for:

THERALOC

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2006-12-28 — Application filed
  • 2007-03-22 — Sn assigned for sect 66a appl from ib
  • 2007-03-23 — Application filed
  • 2007-04-19 — Approved for pub - principal register
  • 2007-04-19 — Assigned to examiner
  • 2007-05-09 — Assigned to lie
  • 2007-05-09 — Law office publication review completed
  • 2007-07-04 — Notice of publication
  • 2007-07-24 — Published for opposition
  • 2007-10-09 — Registered-principal register
  • 2013-08-03 — New representative at ib received
  • 2014-04-07 — Teas section 71 received
  • 2014-05-08 — Case assigned to post registration paralegal
  • 2014-06-19 — Registered-sec.71 accepted
  • 2014-06-19 — Notice of acceptance of sec. 71 - e-mailed
  • 2016-10-09 — Courtesy reminder - sec. 71 (10-yr) e-mailed
  • 2016-12-28 — Final status recorded
  • 2017-07-20 — Death of international registration
  • 2017-07-20 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

Oncoscience AG
DE
Oncoscience AG
DE
Oncoscience AG
DE

Correspondent

Howard J. Shire, Kenyon & Kenyon LLP
One Broadway
NEW YORK, NY 10004
UNITED STATES

Filing Details

Filing Date:
2006-12-28
Status Date:
2016-12-28
Category:
Pharmaceuticals
Filing Year:
2006

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.